Black Rock Inc. Biocept Inc Transaction History

Black Rock Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.88 - $2.27 $36,575 - $94,348	-41,563 Reduced 20.84%	157,913 $148,000
Q1 2022 May 12, 2022	BUY	$1.83 - $3.97 $12,304 - $26,694	6,724 Added 3.49%	199,476 $463,000
Q4 2021 Feb 10, 2022	BUY	$3.43 - $4.22 $4,781 - $5,882	1,394 Added 0.73%	192,752 $698,000
Q3 2021 Nov 09, 2021	SELL	$3.39 - $4.34 $2,712 - $3,472	-800 Reduced 0.42%	191,358 $767,000
Q2 2021 Aug 11, 2021	BUY	$4.03 - $5.07 $774,396 - $974,241	192,158 New	192,158 $805,000

Ticker BIOC
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,922,900
Market Cap $1.18M
Description
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.